Farallon Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-72,398	Closed	-$9.54M	–	182
2023 Q4	$9.54M	Sell	72,398 -375,602	-84%	-$49.5M	0.04%	80
2023 Q3	$50.4M	Buy	+448,000	New	+$50.4M	0.24%	58